News

BKR or CLB: Which Is the Better Value Stock Right Now?

  • Investors looking for stocks in the Oil and Gas - Field Services sector might want to consider either Baker Hughes (BKR) or Core Laboratories (CLB). But which of these two stocks offers value investors a better bang for their buck right now?
    07/10/2024

Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?

  • Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
    05/24/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Core Laboratories N.V. (CLB) can buy. Click on Rating Page for detail.

The price of Core Laboratories N.V. (CLB) is 23.77 and it was updated on 2024-07-17 01:13:27.

Currently Core Laboratories N.V. (CLB) is in undervalued.

News
    
News

Natixis Advisors L.P. Cuts Holdings in Core Laboratories Inc. (NYSE:CLB)

  • Natixis Advisors L.P. decreased its position in Core Laboratories Inc. (NYSE:CLB – Free Report) by 32.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,928 shares of the oil and gas company’s stock after selling 6,265 shares during the period. Natixis Advisors L.P.’s holdings in Core Laboratories were worth $228,000 at the end of the most recent quarter. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in Core Laboratories in the third quarter valued at $31,000. GAMMA Investing LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $48,000. PNC Financial Services Group Inc. increased its stake in shares of Core Laboratories by 72.7% during the third quarter. PNC Financial Services Group Inc. now owns 6,017 shares of the oil and gas company’s stock worth $144,000 after purchasing an additional 2,533 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Core Laboratories by 31.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,787 shares of the oil and gas company’s stock worth $259,000 after purchasing an additional 2,566 shares in the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $288,000. Hedge funds and other institutional investors own 97.81% of the company’s stock. Core Laboratories Stock Performance CLB opened at $18.04 on Monday. The firm has a market capitalization of $846.08 million, a PE ratio of 20.50, a PEG ratio of 1.02 and a beta of 2.40. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $27.94. The firm’s 50-day moving average price is $16.89 and its 200 day moving average price is $16.88. The company has a current ratio of 2.68, a quick ratio of 1.85 and a debt-to-equity ratio of 0.68. Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $129.64 million for the quarter, compared to analyst estimates of $124.47 million. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. As a group, sell-side analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year. Core Laboratories Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Monday, May 6th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 annualized dividend and a yield of 0.22%. Core Laboratories’s payout ratio is 4.55%. Wall Street Analysts Forecast Growth A number of analysts have recently commented on CLB shares. Stifel Nicolaus boosted their target price on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Bank of America lowered their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research report on Monday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.75. Check Out Our Latest Report on Core Laboratories About Core Laboratories (Free Report) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
    Mon, May. 20, 2024

Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript

  • Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
    Thu, Apr. 25, 2024

Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates

  • Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
    Thu, Apr. 25, 2024

CORE LAB REPORTS FIRST QUARTER 2024 RESULTS

  • FIRST QUARTER REVENUE OF $129.6 MILLION, UP MODESTLY SEQUENTIALLY AND YEAR-OVER-YEAR FIRST QUARTER OPERATING INCOME OF $8.6 MILLION; EX-ITEMS, $14.9 MILLION, FLAT SEQUENTIALLY, UP 3% YEAR-OVER-YEAR FIRST QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FIRST QUARTER GAAP EPS OF $0.07; EX-ITEMS, $0.19, FLAT SEQUENTIALLY AND YEAR-OVER-YEAR FIRST QUARTER FREE CASH FLOW OF $2.5 MILLION COMPANY ANNOUNCES Q2 2024 QUARTERLY DIVIDEND HOUSTON , April 24, 2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000.  Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP").
    Wed, Apr. 24, 2024

What Makes Core Laboratories (CLB) a New Strong Buy Stock

  • Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
    Thu, Apr. 18, 2024
SEC Filings
SEC Filings

Core Laboratories N.V. (CLB) - 25-NSE

  • SEC Filings
  • 05/02/2023

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/03/2023

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/21/2023

Core Laboratories N.V. (CLB) - 425

  • SEC Filings
  • 01/17/2023

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/04/2023

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/02/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/03/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/02/2022

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 06/09/2022

Core Laboratories N.V. (CLB) - 424B5

  • SEC Filings
  • 06/09/2022

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/27/2022

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/24/2022

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 05/18/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/02/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/04/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/02/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/17/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/04/2022

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/03/2021

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 10/06/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/05/2021

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 07/12/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/06/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/21/2021

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/28/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/19/2021

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/19/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/05/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/02/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/23/2021

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/16/2021

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 02/09/2021

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/05/2021

Core Laboratories N.V. (CLB) - 424B5

  • SEC Filings
  • 12/17/2020

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 12/09/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/02/2020

Core Laboratories N.V. (CLB) - S-8

  • SEC Filings
  • 08/19/2020

Core Laboratories N.V. (CLB) - S-3ASR

  • SEC Filings
  • 08/13/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/02/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/23/2020

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/21/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/20/2020

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/20/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/19/2020

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/19/2020

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 05/11/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/07/2020

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 04/10/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/02/2020

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 03/24/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/03/2020

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/13/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/12/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/04/2020

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/06/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/03/2020

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/03/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/15/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/03/2019

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/28/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/28/2019

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/28/2019

Core Laboratories N.V. (CLB) - S-8

  • SEC Filings
  • 05/08/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/02/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/12/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/05/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/14/2019

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/13/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/03/2019

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/04/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/30/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 09/05/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 09/04/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/15/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/03/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/03/2018

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 06/05/2018

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/29/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/03/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/09/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/15/2018

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 02/12/2018

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/01/2018

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/03/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/03/2018

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/05/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 09/05/2017

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 06/01/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/05/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/04/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/03/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/16/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/01/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/31/2017

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/04/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/04/2017

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/05/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/03/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 09/02/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/01/2016

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 07/01/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/27/2016

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 06/27/2016

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/31/2016

Core Laboratories N.V. (CLB) - 424B5

  • SEC Filings
  • 05/13/2016

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 05/11/2016

Core Laboratories N.V. (CLB) - S-3ASR

  • SEC Filings
  • 05/11/2016

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 04/19/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/04/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/01/2016

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 03/15/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/02/2016

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/16/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/16/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/03/2016

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/04/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/04/2016

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/02/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/02/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/27/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/01/2015

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/28/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/13/2015

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/07/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/02/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/17/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/03/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/02/2015

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/02/2015

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 01/02/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/02/2015

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/17/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/04/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/31/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/28/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/01/2014

Core Laboratories N.V. (CLB) - SD

  • SEC Filings
  • 05/30/2014

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 04/04/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/02/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/10/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/06/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/04/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/14/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/10/2014

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/03/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/03/2014

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/23/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/07/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/25/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/02/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/20/2013

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/20/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/01/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/24/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/03/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/05/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/26/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/15/2013

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/12/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/05/2013

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/02/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 01/02/2013

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/03/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/21/2012

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 11/06/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/22/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/26/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/25/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/02/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/31/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/29/2012

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/29/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/17/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/27/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/03/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/05/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/27/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/21/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/17/2012

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/14/2012

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/10/2012

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 01/30/2012

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/03/2012

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 12/30/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/05/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/23/2011

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 10/20/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/27/2011

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 07/21/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/01/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/02/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/01/2011

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 06/01/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/17/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/27/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/04/2011

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 03/30/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/02/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/16/2011

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/03/2011

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/03/2011

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/03/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/23/2010

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 07/30/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/30/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/28/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/02/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/20/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/17/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/05/2010

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 04/14/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/05/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/02/2010

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/18/2010

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/12/2010

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 12/08/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/03/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/12/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/09/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/02/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/28/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 09/25/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/17/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/02/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/26/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/19/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 04/02/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/13/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/11/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/03/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/26/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/23/2009

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/19/2009

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 12/24/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 12/03/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/20/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/04/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/30/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 07/16/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/11/2008

Core Laboratories N.V. (CLB) - 3

  • SEC Filings
  • 05/23/2008

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 05/01/2008

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 04/03/2008

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 03/19/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/03/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/28/2008

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/14/2008

Core Laboratories N.V. (CLB) - SC 13G

  • SEC Filings
  • 02/11/2008

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 12/21/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 11/21/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/07/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 11/01/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 10/30/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/21/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/16/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 08/15/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 07/25/2007

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 07/06/2007

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 06/06/2007

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 06/05/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 06/05/2007

Core Laboratories N.V. (CLB) - UPLOAD

  • SEC Filings
  • 05/24/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/16/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 05/11/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 05/03/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 04/27/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 04/10/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 03/12/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 03/07/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 02/28/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/28/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/23/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 02/16/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 02/12/2007

Core Laboratories N.V. (CLB) - 4/A

  • SEC Filings
  • 02/02/2007

Core Laboratories N.V. (CLB) - 4

  • SEC Filings
  • 02/02/2007

Core Laboratories N.V. (CLB) - 424B3

  • SEC Filings
  • 01/29/2007

Core Laboratories N.V. (CLB) - 5

  • SEC Filings
  • 01/24/2007
Press Releases
StockPrice Release
More Headlines
News

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/17/2024

Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term

  • Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
  • 03/29/2024

Core Laboratories Inc. (CLB) Q4 2023 Earnings Call Transcript

  • Core Laboratories Inc. (CLB) Q4 2023 Earnings Call Transcript
  • 02/01/2024

Core Laboratories (CLB) Q4 Earnings Miss Estimates, Sales In Line

  • Core Laboratories' (CLB) first-quarter 2024 revenues are anticipated in the $122-$128 million range, while the operating income is estimated in the band of $11.8-$14.3 million.
  • 02/01/2024

Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings

  • While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
  • 01/31/2024

Core Laboratories (CLB) Q4 Earnings Miss Estimates

  • Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago.
  • 01/31/2024

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS

  • FOURTH QUARTER REVENUE OF $128.2 MILLION, UP 2% SEQUENTIALLY FOURTH QUARTER OPERATING INCOME OF $14.6 MILLION; EX-ITEMS, $15.0 MILLION, DOWN 6% SEQUENTIALLY FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.14; EX-ITEMS, $0.19, DOWN 14% SEQUENTIALLY FOURTH QUARTER FREE CASH FLOW OF $16.7 MILLION FOURTH QUARTER DEBT REDUCED BY $15.0 MILLION OR OVER 8% COMPANY ANNOUNCES Q1 2024 QUARTERLY DIVIDEND FULL YEAR REVENUE OF $510.0 MILLION, UP 4% FULL YEAR OPERATING INCOME OF $54.6 MILLION; EX-ITEMS, $61.2 MILLION, UP 36% FULL YEAR GAAP EPS OF $0.86; EX-ITEMS, EPS OF $0.80, UP 40% HOUSTON , Jan. 31, 2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2023 revenue of $128,200,000. Core's operating income was $14,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP").
  • 01/31/2024

Core Laboratories (CLB) Reports Next Week: What You Should Expect

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 01/24/2024

U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map

  • Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
  • 01/10/2024

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio

  • In the investment space, uncovering stocks to sell with potential pitfalls is as crucial as identifying opportunities. This comprehensive review zooms in on the recent moves of three prominent companies that have sent ripples through the market.
  • 01/09/2024

CORE LABORATORIES' FOURTH QUARTER 2023 WEBCAST AT 7:30 A.M. CST / 8:30 A.M.

  • HOUSTON , Jan. 2, 2024 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will broadcast its fourth quarter 2023 conference call over the Internet at 7:30 a.m. CST / 8:30 a.m.
  • 01/02/2024

3 Oil Stocks to Sell in January Before They Crash and Burn

  • Throughout 2023, energy companies struggled compared to the large rally in 2021 and 2022. The benchmark for energy companies is the Energy Select Sector SPDR Fund (NYSEARCA: XLE ), which had a share price decline of 1% in 2023.
  • 01/02/2024

Down -7.87% in 4 Weeks, Here's Why Core Laboratories (CLB) Looks Ripe for a Turnaround

  • Core Laboratories (CLB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
  • 12/07/2023

3 Energy Stocks Priced Under $100 to Bet on Right Away

  • It's an opportune moment for investors to incorporate energy stocks like The Williams Companies, Inc. (WMB), Matador Resources Company (MTDR) and Core Laboratories Inc. (CLB) in their portfolio.
  • 12/07/2023

Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts

  • Core Laboratories did not meet net sales expectations in the last quarter, but the outlook for international exploration recovery is positive. Demand for reservoir description services is increasing due to automation and digitalization. There are risks from supply chain disruptions, lower exploration investments, and stock price volatility, but the stock may trade at a higher price.
  • 11/09/2023

Core Laboratories (CLB) Q3 Earnings Top, Revenues Miss

  • Core Laboratories (CLB) anticipates revenues in the range of $125-$132 million and operating income in the band of $13.8-$17.3 million for the fourth quarter of 2023. It also expects earnings per share in the 17-23 cents range.
  • 11/03/2023

Core Laboratories (CLB) Reports Q3 Earnings: What Key Metrics Have to Say

  • Although the revenue and EPS for Core Laboratories (CLB) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
  • 11/01/2023

Oil Price Highest in More Than a Year: Bet on These 3 Stocks

  • Crude price is now in its glorious days, calling for investment in energy companies like Matador Resources (MTDR), Pioneer Natural (PXD) and Core Laboratories (CLB).
  • 09/28/2023

Play the 10-Month High Crude Price With These 3 Oilfield Stocks

  • Crude price is now in its glorious days, calling for investment in oilfield service companies like Core Laboratories (CLB), Solaris Oilfield (SOI) and Helix Energy (HLX).
  • 09/15/2023

Tap the Crude Rally With These Three Promising Energy Stocks

  • The decisions of Saudi Arabia & Russia to voluntarily extend oil cuts until the year-end are aiding the crude rally. Solaris (SOI), Core Lab (CLB) and Evolution (EPM) are thus well-poised to gain.
  • 09/07/2023

4 Oilfield Services Stocks to Gain From the Prospering Industry

  • With the expectations that crude prices will remain solid, demand for oilfield services will stay strong, making the outlook for the Zacks Oil & Gas- Field Services industry bright. SLB, HAL, CLB and SOI are expected to benefit the most from this.
  • 09/06/2023

Core Laboratories (CLB) Q2 Earnings Top, Revenues Miss

  • Core Laboratories (CLB) anticipates revenues and operating income in the range of $128-$132 million and $15.2-$17.5 million, respectively, with earnings in the band of 21-25 cents per share for Q3 2023.
  • 07/31/2023

Compared to Estimates, Core Laboratories (CLB) Q2 Earnings: A Look at Key Metrics

  • The headline numbers for Core Laboratories (CLB) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  • 07/26/2023

Core Laboratories (CLB) Tops Q2 Earnings Estimates

  • Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.12 per share a year ago.
  • 07/26/2023

CORE LABORATORIES' SECOND QUARTER 2023 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M.

  • HOUSTON , June 27, 2023 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will broadcast its second quarter 2023 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m.
  • 06/27/2023

Core Laboratories: Green Shoots, But Too Far Down The Road

  • Business is improving for Core Laboratories Inc. at a very modest incremental pace. The company lacks a moat or a near-term catalyst.
  • 05/12/2023

Core Labs (CLB) Q1 Earnings & Sales Beat Estimates

  • Core Labs (CLB) expects second-quarter 2023 revenues of $130-$135 million, earnings of 20-24 cents per share and operating income of $14.5-$17.5 million.
  • 04/28/2023

Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript

  • Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript.
  • 04/27/2023

Core Laboratories (CLB) Q1 Earnings and Revenues Surpass Estimates

  • Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.08 per share a year ago.
  • 04/26/2023

Why Core Laboratories, Gran Tierra Energy, and NexTier Oilfield Solutions Rallied Today

  • Eight members of OPEC+ decided to cut their oil production by a combined 1.16 million barrels per day. The move follows a 2 million barrel per day OPEC+ cut back in October.
  • 04/03/2023

Oil & Gas Service Firms Hit by Stalling Activity Levels in Q1

  • Halliburton (HAL), Core Labs (CLB) and Schlumberger Ltd. (SLB) are likely to have been impacted by poor sentiment, rising costs, and weak prices in Q1.
  • 04/03/2023

Core Laboratories (CLB) Up 0.9% Since Last Earnings Report: Can It Continue?

  • Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
  • 03/03/2023

Why Devon Energy, Phillips 66, and Core Laboratories All Slumped Today

  • A big inventory build in the U.S. and fears of higher interest rates caused these oil-related stocks to fall.
  • 02/17/2023

Core Laboratories (CLB) Q4 Earnings Beat, Revenues Miss

  • Core Labs' (CLB) revenues for the first quarter of 2023 are anticipated in the $125-$129 million range, while the operating income is estimated in the $11.5-$14.5 million band.
  • 02/06/2023

Core Laboratories N.V. (CLB) Q4 2022 Earnings Call Transcript

  • Core Laboratories N.V. (NYSE:CLB ) Q4 2022 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Larry Bruno - Chairman & CEO Chris Hill - CFO Gwen Gresham - SVP & Head, IR Conference Call Participants Samantha Hoh - Evercore ISI Simon Galligani - Awilco AS Operator Good morning, and welcome to the Core Laboratories Fourth Quarter 2022 Earnings Call.
  • 02/02/2023

Core Laboratories (CLB) Surpasses Q4 Earnings Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of 5.26% and 1.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 02/01/2023

Core Laboratories: A Pricey Oil Services Name At Technical Resistance

  • The Energy sector often performs particularly poorly at the onset of a recession, and recent LEI data suggest we might already be in contraction. One energy equipment name features a high EV/EBITDA multiple and technical resistance.
  • 01/25/2023

Core Labs (CLB) Reveals Plans to Transfer Domicile to U.S.

  • Core Labs plans to relocate from the Netherlands to the United States to increase shareholder value over time by streamlining its corporate structure, enhancing operational effectiveness and reducing cost.
  • 01/25/2023

Why ExxonMobil, Chevron, and Core Labs Stocks Popped Today

  • Investors cheered ExxonMobil's predictions -- but they may not have fully understood them at first.
  • 12/08/2022

SLB vs. CLB: Which Stock Is the Better Value Option?

  • SLB vs. CLB: Which Stock Is the Better Value Option?
  • 11/15/2022

Core Laboratories: Likely To Take A Pause, Patience!

  • Core Laboratories N.V. has rallied 30% since our last article. We are taking profits and headed to the sidelines on this quality, but debt-laden, offshore company.
  • 11/12/2022

Why Oil and Gas Stocks Rallied Today, and Why It Might Continue

  • The end of Strategic Petroleum Reserve releases and upcoming sanctions on Russian oil could bolster oil prices.
  • 11/11/2022

Core Laboratories N.V. (CLB) Q3 2022 Earnings Call Transcript

  • Core Laboratories N.V. (NYSE:CLB ) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET Company Participants Larry Bruno - Chairman & Chief Executive Officer Gwen Gresham - Senior Vice President & Head of Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Financial Corporation John Daniel - Daniel Energy Partners Don Crist - Johnson Rice Simon Galligani - Awilco Dan Kutz - Morgan Stanley David Smith - Pickering Energy Advisors Samantha Hoh - Evercore ISI Operator Good morning and welcome to the Core Laboratories Third Quarter 2022 Conference Call.
  • 10/27/2022

SLB or CLB: Which Is the Better Value Stock Right Now?

  • SLB vs. CLB: Which Stock Is the Better Value Option?
  • 10/14/2022

CORE LABORATORIES' THIRD QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M.

  • AMSTERDAM , Sept. 27, 2022 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its third quarter 2022 conference call over the Internet at 7:30 a.m.
  • 09/27/2022

SLB or CLB: Which Is the Better Value Stock Right Now?

  • SLB vs. CLB: Which Stock Is the Better Value Option?
  • 09/23/2022

Oil Field Services: Value Matrix, Momentum, And Market Cap Analysis

  • Even though energy has been the best performing sector of the year by a large margin, deep values remain in under-covered and small cap oilfield services. Fifty-three oilfield service equities were evaluated using a value matrix including factors for value, growth, profitability, ownership, and debt.
  • 09/19/2022

Why Oil Stocks Were in Retreat Today

  • There was some misunderstanding from the White House yesterday, and demand fears loomed again on Thursday.
  • 09/15/2022

SLB vs. CLB: Which Stock Should Value Investors Buy Now?

  • SLB vs. CLB: Which Stock Is the Better Value Option?
  • 08/22/2022

Core Laboratories: A Speculative Buy At Present Levels

  • Core Lab has just come through an awful quarter and its shares are reflective of that. Its legacy offshore reservoir description business could be on the rise, and the company has a number of other levers to pull.
  • 08/12/2022

Why Devon Energy, Tellurian, and Core Laboratories Stocks Rocketed Higher Today

  • It was a great day for beaten-down energy stocks.
  • 08/11/2022

SLB or CLB: Which Is the Better Value Stock Right Now?

  • SLB vs. CLB: Which Stock Is the Better Value Option?
  • 08/05/2022

Why Energy Stocks Dropped on Monday

  • When oil prices fall, it's not surprising to see oil stocks close behind.
  • 08/01/2022

Core Labs (CLB) Q2 Earnings Meet Estimates, Sales Narrowly Beat

  • Core Laboratories' (CLB) second-quarter earnings meet the consensus mark, while revenues marginally outperform the same.
  • 08/01/2022

Why Core Laboratories Stock Sank Today

  • Investors weren't in a particularly forgiving mood after the company unveiled its latest set of quarterly earnings Wednesday night.
  • 07/28/2022

Core Laboratories (CLB) Q2 Earnings Match Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 0.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 07/27/2022

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 07/20/2022

Why Energy Stocks Plunged Today

  • The market is worried that global oil demand could drop if parts of China go back into COVID-19 lockdowns.
  • 07/12/2022

Why Occidental Petroleum, Devon Energy, and Core Laboratories Plunged Today

  • These three energy-related names followed oil prices lower following the Fourth of July weekend.
  • 07/05/2022

Why Chevron, Core Labs, and Phillips 66 Stocks Dropped Today

  • Oil prices are down today, and oil stocks are following them down.
  • 06/23/2022

Why Shares in Core Labs Fell Today

  • A look at today's fall and the underlying dynamics in the stock.
  • 06/22/2022

Why Core Labs Stock Dived by More Than 10% Today

  • Few investors are happy when a company announces a new stock issue.
  • 06/09/2022

Core Laboratories (CLB) Up 2.6% Since Last Earnings Report: Can It Continue?

  • Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
  • 05/27/2022

Core Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales Beat

  • Core Laboratories' (CLB) stock down 3% since the company's first-quarter earnings and revenues beat estimates.
  • 05/06/2022

Why Shares in Core Labs Fell This Week

  • The reservoir optimization company continues to have strong medium-term growth prospects.
  • 04/29/2022

Why Core Laboratories Stock Is Slumping Today

  • The oilfield service company is falling despite posting solid first-quarter results.
  • 04/28/2022

Why Schlumberger, Core Laboratories, and National Energy Services Reunited Plunged Today

  • Oil plunged on fresh Chinese lockdown worries.
  • 04/25/2022

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/20/2022

Core Laboratories: Bullish Into Multi-Year Oil And Gas Investment Cycle

  • Core Laboratories is benefiting from strong conditions in the energy sector. The company sees current oil and gas prices supporting higher sector investments into new development projects as a growth tailwind.
  • 04/13/2022

Core Labs (CLB) Hit by Russia Conflict, Pegs Down Q1 View

  • In addition to the geopolitical risks, Core Laboratories (CLB) suffered operational hiccups after a much larger-than-usual number of its employees tested positive for COVID during the first quarter.
  • 03/17/2022

Core Laboratories (CLB) Moves 14.2% Higher: Will This Strength Last?

  • Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
  • 03/08/2022

Why Is Core Laboratories (CLB) Up 7.1% Since Last Earnings Report?

  • Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
  • 03/04/2022

Core Labs (CLB) Q4 Earnings Meet Estimates, Revenues Surpass

  • Core Laboratories' (CLB) fourth-quarter earnings are on par with the consensus mark, while revenues beat estimates as a result of a strong performance in the Production Enhancement segment.
  • 02/09/2022

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2021 Results - Earnings Call Transcript

  • Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2021 Results - Earnings Call Transcript
  • 02/03/2022

Core Laboratories (CLB) Meets Q4 Earnings Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 02/02/2022

Why ExxonMobil, Occidental Petroleum, and Core Laboratories Surged Double Digits This Week

  • It was a great week for oil stocks amid a busy week of news and a market rotation.
  • 01/07/2022

Why ConocoPhillips, Core Labs, and Centennial Resource Stocks Just Popped

  • OPEC+ isn't scared of omicron. Should you be?
  • 01/04/2022

Core Labs' (CLB) Stock Up 9.4% Despite Missing on Q3 Earnings

  • In the September quarter, Core Labs (CLB) generates $11.9 million as operating cash and its capex totals $3.1 million, leading to an $8.8-million free cash flow (FCF) recognition.
  • 11/10/2021

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q3 2021 Results - Earnings Call Transcript

  • Core Laboratories N.V. (CLB) CEO Larry Bruno on Q3 2021 Results - Earnings Call Transcript
  • 10/28/2021

Why Core Laboratories Stock Is Slumping Today

  • Investors didn't like what the oil-field services company had to report.
  • 10/28/2021

Core Laboratories (CLB) Q3 Earnings and Revenues Lag Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -4.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 10/27/2021

Why Core Laboratories Stock Is Sinking Today

  • An analyst questions the oil-field service company's recovery.
  • 10/18/2021

Core Laboratories: New Services And M&A Could Make The Stock Spike Up

  • Core Laboratories: New Services And M&A Could Make The Stock Spike Up
  • 10/12/2021

Why Shares of Centennial Resource, Core Labs, and Peabody Energy Are on Fire Today

  • Higher oil and gas prices are refueling investor interest in these stocks.
  • 08/23/2021

Why Energy Stocks Are Down This Week

  • Energy stocks took it on the chin this week.
  • 08/19/2021

Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates

  • In the June quarter, Core Labs (CLB) generates $9.5 million in operating cash and its capital expenditure totals $2.9 million, leading to a $6.6-million free cash flow (FCF) recognition.
  • 08/02/2021

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q2 2021 Results - Earnings Call Transcript

  • Core Laboratories N.V. (CLB) CEO Larry Bruno on Q2 2021 Results - Earnings Call Transcript
  • 07/29/2021

Why Shares of Core Laboratories Are Falling Today

  • There were some bright spots in the quarterly earnings report, but investors don't seem to care.
  • 07/29/2021

Core Laboratories (CLB) Lags Q2 Earnings and Revenue Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 07/28/2021

Why Core Labs, Centennial Resource Development, and Transocean Popped in Early Trading Today

  • This trio of energy names got a boost when a key commodity hit an equally key price level.
  • 07/01/2021

Core Laboratories' Second Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M.

  • AMSTERDAM, June 29, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its second quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m.
  • 06/29/2021

Why Core Labs Stock Slumped This Week

  • The oilfield services stock has cooled off after a big run.
  • 06/17/2021

Monday's Analyst Upgrades and Downgrades: Chipotle, CRISPR, Hess Midstream, iMedia, Kinder Morgan, Wendy's and More

  • Monday's futures were relatively flat, with the Nasdaq looking the best out of the group with about a 0.2% gain.
  • 06/14/2021

Why Energy Stocks Are Up Big This Week

  • Several catalysts fueled a rally in the energy market this week.
  • 06/03/2021

Why These Oil Stocks Are Soaring Today

  • An industry leader is getting increasingly bullish on the oil and gas sector.
  • 06/02/2021

Core Laboratories (CLB) Up 33.5% Since Last Earnings Report: Can It Continue?

  • Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
  • 05/21/2021

Core Laboratories: The Upside Appears Priced In

  • Core Laboratories: The Upside Appears Priced In
  • 05/03/2021

Core Laboratories NV (CLB) CEO Lawrence Bruno on Q1 2021 Results - Earnings Call Transcript

  • Core Laboratories NV (CLB) CEO Lawrence Bruno on Q1 2021 Results - Earnings Call Transcript
  • 04/22/2021

Core Labs' (CLB) Q1 Earnings Beat Estimates, Revenues Miss

  • In the March quarter, Core Labs (CLB) generates $8 million in operating cash and its capital expenditure totals $2.8 million, leading to a $5.2-million free cash flow (FCF) recognition.
  • 04/22/2021

Core Laboratories (CLB) Q1 Earnings Top Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 04/21/2021

Recap: Core Laboratories Q1 Earnings

  • Shares of Core Laboratories (NYSE:CLB) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 51.61% over the past year to $0.15, which beat the estimate of $0.13.
  • 04/21/2021

Core Laboratories: Growth Should Continue After The Economy Reopens

  • CLB grew quarterly revenue 8% Q/Q. North America land drilling is showing signs of life. Cost containment efforts and added scale could amplify EBITDA growth.
  • 04/18/2021

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/14/2021

Why Core Laboratories' Shares Popped 7.1% Today

  • Could oil be the cause?
  • 03/24/2021

Core Laboratories' First Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M.

  • AMSTERDAM, March 22, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m.
  • 03/22/2021

Why Core Laboratories Shares Plunged 11.9% Today

  • You can blame oil for most of the drop.
  • 02/23/2021

Schlumberger And Core Laboratories: Oilfield Service Firms In An Oil Upswing

  • In this article, I review how my recent call of going long oilfield service stocks has fared. It's encouraging to see oilfield service stocks began to participate in the bullish upturn of the benchmark oil price.
  • 02/18/2021

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2020 Results - Earnings Call Transcript

  • Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2020 Results - Earnings Call Transcript
  • 01/28/2021

Why Core Laboratories Stock Rose 5% and Fell 5% on the Same Day

  • Shares took a roller coaster ride today, as the big news was earnings.
  • 01/28/2021

Core Laboratories (CLB) Q4 Earnings and Revenues Top Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of 5.88% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 01/27/2021

Schlumberger And Core Laboratories: Industry Condition Is Ripening For Going Long

  • It's time to have a bird's-eye view of the upstream oil industry using information gleaned from a variety of industry sources.
  • 01/27/2021

A Preview Of Core Laboratories's Earnings

  • On Wednesday, January 27, Core Laboratories (NYSE:CLB) will release its latest earnings report. Here is Benzinga's outlook for the company.
  • 01/26/2021

What's in Store for Core Laboratories (CLB) in Q4 Earnings?

  • Core Laboratories' (CLB) cost-saving measures are expected to have driven fourth-quarter earnings and cash flows higher.
  • 01/22/2021

Why Shares of Golar LNG, Enterprise Products Partners, SM Energy, Occidental, and Core Labs Rallied Today

  • The energy markets got a shock, and it rippled across the entire industry landscape. There are lessons here.
  • 01/12/2021

Why These 5 Oil Stocks Were Soaring Today

  • The oil market got a pleasant surprise.
  • 01/05/2021

Why Core Laboratories Stock Sank Today

  • The oil and gas services provider is conducting an at-the-market offering to raise capital.
  • 12/17/2020

John Rogers' Firm Ups Stakes in 2 Companies

  • John Rogers (Trades, Portfolio), leader of Ariel Investments, disclosed earlier this week his firm upped its stakes in Core Laboratories NV (NYSE:CLB) and Madison Square Garden Entertainment Corp. (NYSE:MSGE).
  • 12/10/2020

Why Core Laboratories, SM Energy, and Kosmos Energy Rallied as Much as 12% Today

  • Energy stocks from across the spectrum rose along with the key products the sector produces. Here's what you need to know.
  • 12/10/2020

Why QEP Resources, Kosmos Energy, Helix Energy Solutions, and Core Laboratories All Fell Sharply in Early Trading Today

  • Oil prices were lower today, but investors in the energy patch were watching OPEC and not liking what they saw.
  • 11/30/2020

Why Core Laboratories, Transocean, and Helix Energy Solutions Rallied in Early Trading Today

  • Energy services names got a jolt from excited investors after a third vaccine candidate reported impressive results. Here's what you need to know.
  • 11/23/2020

Why Core Laboratories Stock Jumped 7% at the Open Today

  • Energy services provider Core Labs got a boost from rising oil prices, but it's a tap-on effect from a bigger story unfolding in the news.
  • 11/16/2020

Why Occidental Petroleum, Centennial Resource Development, and Core Labs Rocketed 20% Higher Today

  • There's big news about COVID-19, but it will take some time before this trio sees any benefit. That didn't stop investors.
  • 11/09/2020

Some of the Biggest Oil Stocks Are Crashing With Crude Prices Today

  • The global oil market is in turmoil.
  • 10/28/2020

Project $1M: Salesforce Drives August Returns

  • Project $1M had a strong month in August with the portfolio increasing in value some 10.5% vs. the S&P 500.
  • 08/31/2020

Core Laboratories: The Upside Is Likely Priced In

  • CLB's Q2 revenue fell 24% Q/Q. Demand destruction in the oil industry will likely persist in the short term.
  • 08/18/2020

HAL or CLB: Which Is the Better Value Stock Right Now?

  • HAL vs. CLB: Which Stock Is the Better Value Option?
  • 08/11/2020

EnerCom Announces the Initial Lineup for its Virtual The Oil & Gas Conference® August 17-19, 2020

  • EnerCom, Inc. is pleased to announce the initial lineup for the 25th Anniversary of The Oil and Gas Conference®. EnerCom will continue to announce more companies as they are added to their lineup. You can check the most up-to-date agenda by clicking here.
  • 07/28/2020

Core Laboratories N.V. (CLB) Shares March Higher, Can It Continue?

  • As of late, it has definitely been a great time to be an investor in Core Laboratories N.V. (CLB).
  • 07/28/2020

Wide-Moat Stocks On Sale - The August 2020 Heat Map

  • Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
  • 07/27/2020

Core Laboratories (CLB) Q2 2020 Earnings Call Transcript

  • CLB earnings call for the period ending June 30, 2020.
  • 07/23/2020

Core Labs' (CLB) Q2 Earnings and Sales Surpass Estimates

  • In the June quarter, Core Labs (CLB) generates $27 million in operating cash and its capital expenditure totals $3.1 million, leading to $23.9-million free cash flow (FCF) recognition.
  • 07/23/2020

Core Laboratories NV (CLB) CEO Lawrence Bruno on Q2 2020 Results - Earnings Call Transcript

  • Core Laboratories NV (NYSE:CLB) Q2 2020 Earnings Conference Call July 23, 2020, 08:30 ET Company Participants Lawrence Bruno - Chairman, CEO, President & COO Gwendolyn Schreffler - SVP, Corporate Development & IR Christopher Hill - SVP & CFO Conference Call Participants Scott Gruber - Citigroup Sean Meakim - JPMorgan Chase & Co.
  • 07/23/2020

Core Laboratories (CLB) Q2 Earnings and Revenues Surpass Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of 55.56% and 0.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 07/22/2020

Core Lab Reports Second Quarter 2020 Results From Continuing Operations:

  • Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in second quarter 2020 revenue of $115,700,000. The financial results for the second quarter of 2020 include a charge of $13,300,000 associated with: 1) severance in connection with on-going cost reduction initiatives, 2) a non-cash inventory write-down, and 3) other non-cash charges. Core's operating loss was $2,600,000, with a loss per diluted share of $0.13, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $10,700,000, yielding operating margins of 9.2% and earnings per diluted share ("EPS"), ex-items, of $0.14. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.
  • 07/22/2020

Are Insiders Buying Core Laboratories N.V. (NYSE:CLB) Stock?

  • We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
  • 07/18/2020

Core Lab Announces Q3 2020 Quarterly Dividend

  • The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam Exchange: "CLB NA") ("Core", "Core Lab", or the "Company") has announced a cash dividend of $0.01 per share of common stock payable in the third quarter of 2020. This third quarter dividend amount, if maintained for the fourth quarter of the year, and when added to the Q1 2020 dividend of $0.25 per share and the Q2 2020 dividend of $0.01 per share, would mean a total payout for the year of $0.28 per share of common stock. The third quarter $0.01 per share cash dividend will be payable on Monday, 10 August 2020, to shareholders of record on Monday, 27 July 2020. Dutch withholding tax will be deducted from the dividend at a rate of 15%.
  • 07/17/2020

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 07/15/2020

Hedge Funds Are Selling Core Laboratories N.V. (CLB)

  • The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
  • 06/28/2020

Core Labs Adjusts Credit Facility, Grows Annual Cost Savings

  • Core Laboratories (CLB) enters the second phase of cost management wherein total annualized cost savings are now projected at $61 million and quarterly savings, expected to cross $15 million.
  • 06/25/2020

Core Lab Announces:

  • Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") announced today that the Company's revolving credit facility has been amended effective 22 June 2020 (as amended, the "Credit Facility"). The material terms of the amendment are further described below. The Company has also provided an update on the expansion of approved cost reduction initiatives in response to current market volatility, operational disruption related to COVID-19, and the oil and gas industry outlook, and confirmed the timing of the second quarter 2020 earnings webcast.
  • 06/23/2020

Why Core Labs Stock Crashed Today When Other Oil Stocks Went Up

  • Shares of the oil-reservoir analysis and services company are headed the opposite direction from its peers.
  • 06/15/2020

Core Laboratories Nv Scores Relative Strength Rating Upgrade To 91

  • When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Core Laboratories Nv, which saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 88 to 91. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
  • 06/12/2020

Shares of several energy companies are trading higher after OPEC+ agreed to extend production cuts into July.

  • 06/08/2020

33 Stocks Moving in Monday's Pre-Market Session

  • 06/08/2020

Shares of several energy companies are trading higher amid a gain in oil prices following positive US jobs data and as investors await the OPEC+ conference, hoping for output cuts.

  • 06/05/2020

Better Buy: Baker Hughes vs. Core Laboratories N.V.

  • If you like investing when there's blood in the streets, you might be looking at Baker Hughes and Core Labs. Is one a better option?
  • 05/29/2020

Why Is Core Laboratories (CLB) Up 31.8% Since Last Earnings Report?

  • Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  • 05/22/2020

Morgan Stanley Maintains Equal-Weight on Core Laboratories, Raises Price Target to $18

  • 05/19/2020

96 Biggest Movers From Friday

  • 05/11/2020

Shares of several energy companies are trading higher after US unemployment figures came in below consensus estimates. Equities have been strong this week amid a rebound in oil prices and some US states easing lockdown restrictions.

  • 05/08/2020

Why Core Labs, Halliburton, and Baker Hughes Shot Higher in April

  • After oil supply surged in March, investors took a more positive view in April. But this story is far from over, especially for this trio.
  • 05/05/2020

Earnings During A Pandemic

  • 05/04/2020

Why Oil Stocks Are Slumping Today

  • The volatility in the oil and gas markets continues.
  • 05/01/2020

Oil & Gas Stock Roundup: BP, Kinder Morgan & Baker Hughes Report Q1 Earnings

  • BP plc (BP) missed earnings estimates, Kinder Morgan (KMI) reported in line, while Baker Hughes (BKR) came out with better-than-expected bottom-line number.
  • 04/30/2020

Oil & Gas Stock Roundup: BP, Kinder Morgan & Baker Hughes Report Q1 Earnings

  • BP plc (BP) missed earnings estimates, Kinder Morgan (KMI) reported in line, while Baker Hughes (BKR) came out with better-than-expected bottom-line number.
  • 04/30/2020

Oil & Gas Stock Roundup: BP, Kinder Morgan & Baker Hughes Report Q1 Earnings

  • 04/30/2020

Analysts Offer Insights on Services Companies: United Parcel (UPS), Hilton Worldwide Holdings (HLT) and Apergy (APY)

  • Analysts fell to the sidelines weighing in on United Parcel (UPS), Hilton Worldwide Holdings (HLT) and Apergy (APY) with neutral ratings, indicating that
  • 04/29/2020

Analysts Offer Insights on Services Companies: United Parcel (NYSE: UPS), Hilton Worldwide Holdings (NYSE: HLT) and Apergy (NYSE: APY)

  • Analysts fell to the sidelines weighing in on United Parcel (UPS – Research Report), Hilton Worldwide Holdings (HLT – Research
  • 04/29/2020

Why Core Labs Stock Blasted 13% Higher on Wednesday

  • This energy services company reported terrible earnings a week ago, but in today's wild oil market, that's ancient history.
  • 04/29/2020

Shares of several oil companies are trading higher as oil prices gain after EIA reported a smaller-than-expected build in crude inventories. Positive sentiment also potentially being driven by some US states reopening and positive trial data from Gilead's coronavirus treatment candidate.

  • 04/29/2020

Core Lab Announces Q2 2020 Quarterly Dividend

  • The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam Exchange: "CLB NA") has announced a cash dividend of $0.01 per share of common stock payable in the second quarter of 2020. This second quarter dividend amount, if maintained for the remaining quarters of the year, and when added to the Q1 2020 dividend of $0.25 per share, would mean a total payout for the year of $0.28 per share of common stock. The second quarter $0.01 per share cash dividend will be payable on Tuesday, 19 May 2020, to shareholders of record on Friday, 8 May 2020. Dutch withholding tax will be deducted from the dividend at a rate of 15%.
  • 04/28/2020

Why Enphase Energy Stock Popped Today

  • What happened Shares of Enphase Energy (NASDAQ: ENPH) have popped today, up by 17% as of 1 p.m. EDT, after S&P; Dow Jones Indices announced that it would be adding the company to the S&P; MidCap 400 index.
  • 04/28/2020

Shares of several energy companies are trading higher for the session as some US states ease lockdown restrictions and as investors weigh quarterly earnings from blue chip companies.

  • 04/28/2020

Core Laboratories (NYSE:CLB) Price Target Raised to $15.00 at Stifel Nicolaus

  • Core Laboratories (NYSE:CLB) had its price objective upped by Stifel Nicolaus from $14.00 to $15.00 in a research note released on Friday morning, BenzingaRatingsTable reports. The brokerage currently has a hold rating on the oil and gas company’s stock. Several other research analysts also recently issued reports on CLB. Scotiabank lowered their price objective on […]
  • 04/28/2020

Core Lab Announces Q— —…—… Quarterly Dividend

  • 04/28/2020

Enphase Energy and Paylocity Set to Join S&P MidCap 400; Core Laboratories and Meredith to Join S&P SmallCap 600

  • S&P; Dow Jones Indices will make the following changes to the S&P; MidCap 400 and S&P; SmallCap 600 effective prior to the open of trading on Friday, May 1:
  • 04/27/2020

Enphase, Paylocity gain amid S&P index moves

  • Enphase Energy (NASDAQ:ENPH) is up 5.1% postmarket after news that it's replacing Core Laboratories (NYSE:CLB) in the S&P MidCap 400. Core Labs is moving down to the S&P SmallCap 600 to repla
  • 04/27/2020

S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices ENPH;CLB;AKRX;PCTY;MDP;DO

  • S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices ENPH CLB AKRX PCTY MDP DO
  • 04/27/2020

Analysts Conflicted on These Services Names: Core Laboratories (CLB), Cheniere Energy (LNG) and Ebay (EBAY)

  • Companies in the Services sector have received a lot of coverage today as analysts weigh in on Core Laboratories (CLB), Cheniere Energy (LNG) and Ebay
  • 04/27/2020

Macquarie Group Ltd. Has $2.63 Million Stake in Core Laboratories (NYSE:CLB)

  • Macquarie Group Ltd. increased its stake in shares of Core Laboratories (NYSE:CLB) by 8.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,913 shares of the oil and gas company’s stock after buying an additional 5,668 shares during the quarter. […]
  • 04/27/2020

Core Laboratories to replace Akorn in S&P 600 at open on 5/1 CLB;AKRX

  • Core Laboratories to replace Akorn in S&P 600 at open on 5/1 CLB AKRX
  • 04/27/2020

Enphase Energy to replace Core Laboratories in S&P 400 at open on 5/1 ENPH;CLB

  • Enphase Energy to replace Core Laboratories in S&P 400 at open on 5/1 ENPH CLB
  • 04/27/2020

Enphase Energy and Paylocity Set to Join S&P MidCap 4……; Core Laboratories and Meredith ...

  • 04/27/2020

Core Laboratories (NYSE:CLB) Downgraded by TheStreet to "D"

  • TheStreet downgraded shares of Core Laboratories (NYSE:CLB) from a c rating to a d rating in a research note issued to investors on Wednesday morning, TheStreetRatingsTable reports. Other equities analysts also recently issued research reports about the stock. Scotiabank cut their price target on shares of Core Laboratories from $40.00 to $13.00 in a report […]
  • 04/26/2020

Stocks To Watch: Tech Powerhouses Lead Earnings Blitz

  • Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
  • 04/25/2020

Core Laboratories Target of Unusually Large Options Trading (NYSE:CLB)

  • Core Laboratories (NYSE:CLB) was the target of some unusual options trading activity on Thursday. Stock traders acquired 583 call options on the stock. This represents an increase of approximately 721% compared to the typical volume of 71 call options. A number of analysts recently weighed in on the stock. Bernstein Bank assumed coverage on shares […]
  • 04/25/2020

Stifel Maintains Hold on Core Laboratories, Raises Price Target to $15

  • 04/24/2020

76 Biggest Movers From Yesterday

  • Gainers Oasis Petroleum Inc. (NYSE: OAS) shares climbed 134.7% to close at $0.67 on Thursday. Whiting Petroleum Corporation (NYSE: WLL) surged 100.7% to close at $1.68 after...
  • 04/24/2020

Investmentaktiengesellschaft Fuer Langfristige Inv Buys Carvana Co, Univar Solutions Inc, Visa ...

  • 04/24/2020

Edited Transcript of CLB earnings conference call or presentation 23-Apr-20 12:30pm GMT

  • Q1 2020 Core Laboratories NV Earnings Call
  • 04/23/2020

Core Laboratories NV (CLB) Q1 2020 Earnings Call Transcript

  • CLB earnings call for the period ending March 31, 2020.
  • 04/23/2020

Core Laboratories N.V. (CLB) CEO David Demshur on Q1 2020 Results - Earnings Call Transcript

  • Start Time: 08:30 End Time: 09:31 Core Laboratories N.V. (NYSE:CLB) Q1 2020 Earnings Conference Call April 23, 2020, 08:30 AM ET Company Participants David Dems
  • 04/23/2020

Core Labs' (CLB) Q1 Earnings Miss, Sales Beat Estimates

  • In a bid to sustain a strong balance sheet and lower the debt load, Core Labs (CLB) trims its quarterly cash dividend to a penny per share from the prior dividend of 25 cents.
  • 04/23/2020

Core Labs' (CLB) Q1 Earnings Miss, Sales Beat Estimates

  • In a bid to sustain a strong balance sheet and lower the debt load, Core Labs (CLB) trims its quarterly cash dividend to a penny per share from the prior dividend of 25 cents.
  • 04/23/2020

$151.62 Million in Sales Expected for Core Laboratories (NYSE:CLB) This Quarter

  • Brokerages expect Core Laboratories (NYSE:CLB) to report sales of $151.62 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Core Laboratories’ earnings, with estimates ranging from $149.97 million to $152.90 million. Core Laboratories posted sales of $169.19 million during the same quarter last year, which suggests a negative […]
  • 04/23/2020

Core Labs' (CLB) Q1 Earnings Miss, Sales Beat Estimates

  • 04/23/2020

Core Labs slips after Q1 results; CEO Demshur to accelerate retirement

  • Core Laboratories (NYSE:CLB) -3.7% after-hours following a slight Q1 earnings miss on a 10% Y/Y revenue decline to $152M.The company says Q1 free cash flow totaled $18.7M, marking the 74th consecutive
  • 04/22/2020

Core Laboratories (CLB) Lags Q1 Earnings Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of -8.82% and 0.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 04/22/2020

Core Laboratories (CLB) Lags Q1 Earnings Estimates

  • Core Laboratories (CLB) delivered earnings and revenue surprises of -8.82% and 0.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 04/22/2020

Core Laboratories: 1Q Earnings Snapshot

  • AMSTERDAM (AP) _ Core Laboratories NV (CLB) on Wednesday reported a first-quarter loss of $108.4 million, after reporting a profit in the same period a year earlier. The Amsterdam-based company said it had a loss of $2.44 per share. Earnings, adjuste
  • 04/22/2020

Core Lab Reports First Quarter 2020 Results From Continuing Operations:

  • Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in first quarter 2020 revenue of $152,400,000. The financial results for the first quarter of
  • 04/22/2020

Surging Oil Prices Are Sending These Oil Stocks Swinging Wildly Today

  • Shares of oil-field service providers are moving higher today, but the outlook remains incredibly bleak.
  • 04/22/2020

Core Laboratories reports COVID-19 impact mitigation measures CLB

  • Core Laboratories reports COVID-19 impact mitigation measures CLB
  • 04/22/2020

Core Laboratories reports Q1 adjusted EPS 31c, consensus 35c CLB

  • Core Laboratories reports Q1 adjusted EPS 31c, consensus 35c CLB
  • 04/22/2020

Core Laboratories Q1 Adj. EPS $0.310 Misses $0.350 Estimate, Sales $152.400M Miss $153.860M Estimate

  • 04/22/2020

Core Laboratories Q1 2020 Earnings Preview

  • Core Laboratories (NYSE:CLB) is scheduled to announce Q1 earnings results on Wednesday, April 22nd, after market close.The consensus EPS Estimate is $0.33 (-25.0% Y/Y) and the consensus Revenue Estima
  • 04/21/2020

Douglas Lane & Associates LLC Has $3.90 Million Stock Position in Core Laboratories (NYSE:CLB)

  • Douglas Lane & Associates LLC grew its holdings in shares of Core Laboratories (NYSE:CLB) by 39.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 377,565 shares of the oil and gas company’s stock after acquiring an additional 107,012 shares during the period. Douglas Lane & Associates LLC […]
  • 04/21/2020

Scotiabank Lowers Core Laboratories (NYSE:CLB) Price Target to $13.00

  • Core Laboratories (NYSE:CLB) had its target price decreased by analysts at Scotiabank from $40.00 to $13.00 in a report released on Sunday, Benzinga reports. Scotiabank’s target price indicates a potential upside of 8.70% from the stock’s current price. A number of other research analysts have also commented on CLB. Bank of America lowered Core Laboratories […]
  • 04/21/2020

Analysts Expect Core Laboratories (NYSE:CLB) Will Post Earnings of $0.35 Per Share

  • Brokerages expect Core Laboratories (NYSE:CLB) to announce earnings per share (EPS) of $0.35 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Core Laboratories’ earnings. The lowest EPS estimate is $0.31 and the highest is $0.36. Core Laboratories posted earnings of $0.44 per share in the same quarter […]
  • 04/21/2020

Norges Bank Takes Position in Core Laboratories (NYSE:CLB)

  • Norges Bank purchased a new position in shares of Core Laboratories (NYSE:CLB) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 437,916 shares of the oil and gas company’s stock, valued at approximately $16,496,000. Norges Bank owned approximately 0.99% of […]
  • 04/20/2020

Core Laboratories (CLB) to Release Quarterly Earnings on Wednesday

  • Core Laboratories (NYSE:CLB) is scheduled to release its earnings data after the market closes on Wednesday, April 22nd. Analysts expect Core Laboratories to post earnings of $0.37 per share for the quarter. Core Laboratories has set its Q1 2020 After-Hours guidance at 0.39-0.41 EPS and its Q1 guidance at $0.39-0.41 EPS.Investors that are interested in […]
  • 04/20/2020

Geode Capital Management LLC Has $13.23 Million Holdings in Core Laboratories (NYSE:CLB)

  • Geode Capital Management LLC reduced its holdings in Core Laboratories (NYSE:CLB) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 351,179 shares of the oil and gas company’s stock after selling 3,294 shares during the quarter. Geode Capital Management LLC owned […]
  • 04/19/2020

Were Hedge Funds Right About Edgewell Personal Care Company (EPC)?

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 04/18/2020

Were Hedge Funds Right About Park National Corporation (PRK)?

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 04/18/2020

Were Hedge Funds Right About Core Laboratories N.V. (CLB)?

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 04/18/2020

Earnings Heat Up And Gold On Display

  • Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
  • 04/18/2020

The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International

  • The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International
  • 04/17/2020

The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International

  • The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International
  • 04/17/2020

Core Laboratories (NYSE:CLB) Given Consensus Recommendation of "Hold" by Analysts

  • Shares of Core Laboratories (NYSE:CLB) have received a consensus rating of “Hold” from the seventeen ratings firms that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and three have given a buy recommendation to the company. The average 12-month […]
  • 04/17/2020

The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International

  • 04/17/2020

RBC Capital Thinks Core Laboratories' Stock is Going to Recover

  • RBC Capital analyst Kurt Hallead maintained a Buy rating on Core Laboratories (CLB) on April 14 and set a price target of $13.00. The company's shares
  • 04/16/2020

A Pre-Earnings Analysis of the Oilfield Services Sector

  • The oilfield service companies' Q1 earnings are likely to bear scars of activity slump on account of coronavirus-induced crude price plunge.
  • 04/16/2020

Shares of several energy companies are trading lower after OPEC further cut global oil demand forecasts.

  • 04/16/2020

Hedge Funds Have Never Been This Bullish On Rush Enterprises, Inc. (RUSHA)

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 04/15/2020

Ballard Power Systems Inc. (BLDP): Hedge Funds In Wait-and-See Mode

  • We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
  • 04/15/2020

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/15/2020

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

  • Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/15/2020

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

  • 04/15/2020

Solid Diagnostics to Aid Abbott (ABT) Q1 Earnings Amid Crisis?

  • Though the magnitude of loss due to the virus outbreak in Abbott's (ABT) Core Laboratory business is still unclear, the company's point-of-care business is anticipated to generate profit.
  • 04/14/2020

19 Energy Stocks Moving In Tuesday's Pre-Market Session

  • Gainers • Core Laboratories, Inc. (NYSE:CLB) shares moved upwards by 7.96% to $12.75 during Tuesday's pre-market session. The most recent rating by ScotiaBank, on Apr 13...
  • 04/14/2020

Should Value Investors Pick Core Laboratories (CLB) Stock?

  • Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.
  • 04/13/2020

Should Value Investors Pick Core Laboratories (CLB) Stock?

  • Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.
  • 04/13/2020

The Bottom Fishing Club: Core Labs

  • Core Labs has undergone a dramatic decline in stock price during 2018-20, despite holding a profitable operating business in oilfield services. Depressed valuat
  • 04/13/2020

10 Biggest Price Target Changes For Monday

  • Wedbush cut Starbucks Corporation (NASDAQ: SBUX) price target from $84 to $71. Starbucks closed at $73.88 on Thursday. KeyBanc raised the price target for Alibaba Group...
  • 04/13/2020

Core Labs Could Fly Higher

  • Core Labs is down over 80% over free falling oil prices. I believe much of the downside is priced in. Cost containment efforts allowed the company to deliver an
  • 04/13/2020

Nuveen Asset Management LLC Grows Stock Holdings in Core Laboratories (NYSE:CLB)

  • Nuveen Asset Management LLC grew its holdings in Core Laboratories (NYSE:CLB) by 8,936.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 514,431 shares of the oil and gas company’s stock after acquiring an additional 508,738 shares during the period. Nuveen Asset Management LLC […]
  • 04/13/2020

Core Laboratories upgraded to Outperform from Sector Perform at Scotiabank CLB

  • Core Laboratories upgraded to Outperform from Sector Perform at Scotiabank Scotiabank CLB
  • 04/13/2020

Core Laboratories (NYSE:CLB) Rating Increased to Buy at Scotiabank

  • Core Laboratories (NYSE:CLB) was upgraded by analysts at Scotiabank to a “buy” rating in a report released on Sunday, TipRanks reports. The brokerage currently has a $13.00 price objective on the oil and gas company’s stock. Scotiabank’s target price would suggest a potential upside of 11.40% from the company’s previous close. CLB has been the […]
  • 04/13/2020

ScotiaBank Upgrades Core Laboratories to Sector Outperform, Lowers Price Target to $13

  • 04/13/2020

What Is Core Laboratories’s (NYSE:CLB) P/E Ratio After Its Share Price Rocketed?

  • Those holding Core Laboratories (NYSE:CLB) shares must be pleased that the share price has rebounded 45% in the last...
  • 04/12/2020

What Is Core Laboratories's (NYSE:CLB) P/E Ratio After Its Share Price Rocketed?

  • Those holding Core Laboratories (NYSE:CLB) shares must be pleased that the share price has rebounded 45% in the last...
  • 04/12/2020

Man Group plc Invests $342,000 in Core Laboratories (NYSE:CLB)

  • Man Group plc acquired a new position in shares of Core Laboratories (NYSE:CLB) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,080 shares of the oil and gas company’s stock, valued at approximately $342,000. Other large investors also […]
  • 04/12/2020

Stocks To Watch: Big Banks And Vaccine Players In The Spotlight

  • Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
  • 04/11/2020

Piper Sandler Weighs in on Core Laboratories' Q2 2020 Earnings (NYSE:CLB)

  • Core Laboratories (NYSE:CLB) – Equities researchers at Piper Sandler cut their Q2 2020 EPS estimates for shares of Core Laboratories in a research note issued to investors on Tuesday, April 7th. Piper Sandler analyst I. Macpherson now forecasts that the oil and gas company will earn $0.10 per share for the quarter, down from their […]
  • 04/11/2020

Goldman Sachs Group Inc. Purchases 3,382 Shares of Core Laboratories (NYSE:CLB)

  • Goldman Sachs Group Inc. grew its position in shares of Core Laboratories (NYSE:CLB) by 3.0% in the fourth quarter, Holdings Channel reports. The fund owned 115,898 shares of the oil and gas company’s stock after buying an additional 3,382 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Core Laboratories were worth $4,366,000 at […]
  • 04/10/2020

Piper Sandler Comments on Core Laboratories' Q1 2020 Earnings (NYSE:CLB)

  • Core Laboratories (NYSE:CLB) – Equities research analysts at Piper Sandler cut their Q1 2020 earnings per share (EPS) estimates for Core Laboratories in a report released on Tuesday, April 7th. Piper Sandler analyst I. Macpherson now forecasts that the oil and gas company will earn $0.35 per share for the quarter, down from their prior […]
  • 04/10/2020

Core Laboratories (NYSE:CLB) PT Lowered to $7.50 at Piper Sandler

  • Core Laboratories (NYSE:CLB) had its price target dropped by investment analysts at Piper Sandler from $16.50 to $7.50 in a research note issued to investors on Tuesday, BenzingaRatingsTable reports. The brokerage currently has a “neutral” rating on the oil and gas company’s stock. Piper Sandler’s price target would indicate a potential downside of 32.00% from […]
  • 04/09/2020

Guggenheim Capital LLC Buys 1,100 Shares of Core Laboratories (NYSE:CLB)

  • Guggenheim Capital LLC boosted its stake in shares of Core Laboratories (NYSE:CLB) by 12.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,060 shares of the oil and gas company’s stock after purchasing an additional 1,100 shares during the […]
  • 04/08/2020

Why Shares of Energy Services Companies Like Core Labs Fell as Much as 61% in March

  • COVID-19 took its toll on the market in March, but there was so much more going on in the energy sector.
  • 04/07/2020

Piper Sandler Maintains Neutral on Core Laboratories, Lowers Price Target to $7.5

  • 04/07/2020

Wall Street Analysts Are Neutral on Top Materials Picks

  • Analysts fell to the sidelines weighing in on Helmerich & Payne (HP), Propetro Holding (PUMP) and Select Energy Services (WTTR) with neutral ratings,
  • 04/06/2020

Buy this energy group, Bernstein says after seven-year bearish view

  • News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
  • 04/06/2020

Core Laboratories Company Profile: Stock Performance & Earnings | PitchBook

  • Information on stock, financials, earnings, subsidiaries, investors, and executives for Core Laboratories. Use the PitchBook Platform to explore the full profile.
  • 04/06/2020

RBC Capital Thinks Core Laboratories' Stock is Going to Recover

  • In a report issued on April 3, Kurt Hallead from RBC Capital maintained a Buy rating on Core Laboratories (CLB), with a price target of $13.00. The
  • 04/06/2020

Kopion Asset Management, LLC Buys Pros Holdings Inc, Hexcel Corp, BorgWarner Inc, Sells Ansys ...

  • 04/06/2020

Core Laboratories N.V. (NYSE:CLB) Earns Among The Best Returns In Its Industry

  • Today we'll evaluate Core Laboratories N.V. (NYSE:CLB) to determine whether it could have potential as an investment...
  • 04/03/2020

First Republic Investment Management Inc. Lowers Position in Core Laboratories (NYSE:CLB)

  • First Republic Investment Management Inc. cut its stake in Core Laboratories (NYSE:CLB) by 31.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,649 shares of the oil and gas company’s stock after selling 3,040 shares during the quarter. First Republic Investment […]
  • 04/03/2020

Bank of America Corp DE Cuts Holdings in Core Laboratories (NYSE:CLB)

  • Bank of America Corp DE trimmed its holdings in shares of Core Laboratories (NYSE:CLB) by 5.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 436,464 shares of the oil and gas company’s stock after selling 23,254 shares during the period. […]
  • 04/03/2020

Core Laboratories (NYSE:CLB) Lowered to Strong Sell at ValuEngine

  • Core Laboratories (NYSE:CLB) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a note issued to investors on Thursday, ValuEngine reports. Other research analysts have also issued reports about the company. Citigroup cut their price target on Core Laboratories from $40.00 to $11.00 and set a “neutral” […]
  • 04/02/2020

Amundi Pioneer Asset Management Inc. Purchases 3,880 Shares of Core Laboratories (NYSE:CLB)

  • Amundi Pioneer Asset Management Inc. lifted its position in Core Laboratories (NYSE:CLB) by 155.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 6,371 shares of the oil and gas company’s stock after purchasing an additional 3,880 shares during the quarter. Amundi Pioneer Asset Management […]
  • 03/31/2020

Core Laboratories (NYSE:CLB) Position Increased by Credit Suisse AG

  • Credit Suisse AG raised its holdings in shares of Core Laboratories (NYSE:CLB) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 52,887 shares of the oil and gas company’s stock after purchasing an additional 1,160 shares during the period. […]
  • 03/28/2020

Core Lab Reschedules Time And Location Of Its 2020 Annual Shareholder Meeting While Maintaining Meeting Date Of May 20, 2020

  • Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA"), (the "Company" or "Core Lab") announces that on March 20, 2020, it filed its definitive proxy on form DEF-14A with the U.S. Securities and Exchange Commission (the "SEC") setting the Company's 2020 annual shareholder meeting in Amsterdam, the Netherlands, for May 20, 2020 at 9:00 a.m. CEST.
  • 03/27/2020

Baird Financial Group Inc. Has $9.28 Million Stock Holdings in Core Laboratories (NYSE:CLB)

  • Baird Financial Group Inc. decreased its holdings in shares of Core Laboratories (NYSE:CLB) by 42.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 246,384 shares of the oil and gas company’s stock after selling 184,826 shares during the quarter. Baird Financial Group […]
  • 03/27/2020

Core Lab Reschedules Time And Location Of Its —…—… Annual Shareholder Meeting While ...

  • 03/27/2020

Core Laboratories' First Quarter 2020 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 23, 2020

  • Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2020 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 23, 2020.
  • 03/26/2020

Core Laboratories' First Quarter —…—… Webcast At 7:'… A.M. CDT / —:'… P.M. ...

  • 03/26/2020

Prudential Financial Inc. Raises Position in Core Laboratories (NYSE:CLB)

  • Prudential Financial Inc. raised its holdings in shares of Core Laboratories (NYSE:CLB) by 9.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,515 shares of the oil and gas company’s stock after acquiring an additional 2,300 shares during the quarter. Prudential Financial Inc. […]
  • 03/24/2020

Raymond James & Associates Has $3.85 Million Stake in Core Laboratories (NYSE:CLB)

  • Raymond James & Associates decreased its stake in shares of Core Laboratories (NYSE:CLB) by 16.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 102,212 shares of the oil and gas company’s stock after selling 20,261 shares during the period. Raymond James & Associates’ holdings in Core Laboratories were worth $3,850,000 at the end […]
  • 03/23/2020

Core Laboratories (NYSE:CLB) Given Average Rating of "Hold" by Brokerages

  • Core Laboratories (NYSE:CLB) has earned a consensus rating of “Hold” from the fifteen research firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. The average 1-year target price […]
  • 03/23/2020

AlphaCrest Capital Management LLC Cuts Holdings in Core Laboratories (NYSE:CLB)

  • AlphaCrest Capital Management LLC reduced its position in Core Laboratories (NYSE:CLB) by 51.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,812 shares of the oil and gas company’s stock after selling 9,410 shares during the quarter. AlphaCrest Capital Management LLC’s holdings in Core […]
  • 03/22/2020

How Does Core Laboratories's (NYSE:CLB) P/E Compare To Its Industry, After The Share Price Drop?

  • To the annoyance of some shareholders, Core Laboratories (NYSE:CLB) shares are down a considerable 71% in the last...
  • 03/20/2020

How Does Core Laboratories’s (NYSE:CLB) P/E Compare To Its Industry, After The Share Price Drop?

  • To the annoyance of some shareholders, Core Laboratories (NYSE:CLB) shares are down a considerable 71% in the last...
  • 03/20/2020

Why Oil-Field Services Stocks Are Bouncing Back Today

  • Oil prices are rebounding off their recent bottom, providing some relief for oil-field service companies.
  • 03/19/2020

Is Core Laboratories N.V.’s (NYSE:CLB) ROE Of 52% Impressive?

  • While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
  • 03/19/2020

Morgan Stanley Lowers Core Laboratories (NYSE:CLB) Price Target to $12.00

  • Core Laboratories (NYSE:CLB) had its target price decreased by equities research analysts at Morgan Stanley from $45.00 to $12.00 in a research report issued on Monday, BenzingaRatingsTable reports. The firm currently has an “equal weight” rating on the oil and gas company’s stock. Morgan Stanley’s target price points to a potential upside of 50.19% from […]
  • 03/18/2020

Evercore ISI Downgrades Core Laboratories (NYSE:CLB) to Hold

  • Core Laboratories (NYSE:CLB) was downgraded by investment analysts at Evercore ISI to a “hold” rating in a report released on Tuesday, TipRanks reports. CLB has been the topic of a number of other reports. Bank of America downgraded Core Laboratories from a “buy” rating to an “underperform” rating in a research note on Monday, March […]
  • 03/18/2020

Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $14

  • 03/18/2020

Core Laboratories (CLB) Receives a Hold from J.P. Morgan

  • J.P. Morgan analyst Sean Meakim maintained a Hold rating on Core Laboratories (CLB) today and set a price target of $16.00. The company's shares closed
  • 03/17/2020

NumerixS Investment Technologies Inc Purchases New Shares in Core Laboratories (NYSE:CLB)

  • NumerixS Investment Technologies Inc purchased a new stake in shares of Core Laboratories (NYSE:CLB) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,300 shares of the oil and gas company’s stock, valued at approximately $87,000. Other institutional investors have also […]
  • 03/17/2020

Short Interest in Core Laboratories (NYSE:CLB) Expands By 7.2%

  • Core Laboratories (NYSE:CLB) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 3,440,000 shares, an increase of 7.2% from the February 13th total of 3,210,000 shares. Based on an average trading volume of 965,500 shares, the short-interest ratio is presently 3.6 days. Approximately […]
  • 03/17/2020

JP Morgan Maintains Neutral on Core Laboratories, Lowers Price Target to $16

  • 03/17/2020

Core Labs to cut 2020 capex below 2016 levels, slashes dividend to $0.01

  • Core Laboratories (NYSE:CLB) says it is cutting its full-year capital spending to below its 2016 level of $11.4M and making further corporate and operating cost reductions in reaction to the coronavir
  • 03/16/2020

Core Lab Announces Reduced Dividend And Expansion Of Cost Reduction Initiatives

  • Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") is announcing immediate actions in response to current market volatility, operational disruption related to COVID-19, and the oil and gas industry outlook. In addition, Core Lab is making further corporate and operating cost reductions and reducing its 2020 capital expenditure program to align with the Company's client activity. The Company also feels it is appropriate to withdraw its first quarter 2020 guidance, last provided on January 29, 2020.
  • 03/16/2020

Core Laboratories withdraws Q1 guidance CLB

  • Core Laboratories withdraws Q1 guidance CLB
  • 03/16/2020

Core Laboratories cuts quarterly dividend to 1c from 25c per share CLB

  • Core Laboratories cuts quarterly dividend to 1c from 25c per share CLB
  • 03/16/2020

Fmr LLC Has $751,000 Stock Holdings in Core Laboratories (NYSE:CLB)

  • Fmr LLC decreased its position in shares of Core Laboratories (NYSE:CLB) by 6.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,933 shares of the oil and gas company’s stock after selling 1,301 shares during the period. Fmr LLC’s holdings in Core Laboratories […]
  • 03/16/2020

Core Laboratories (NYSE:CLB) Expected to Post Q1 2020 Earnings of $0.38 Per Share

  • Core Laboratories (NYSE:CLB) – Equities research analysts at Piper Sandler lowered their Q1 2020 earnings estimates for shares of Core Laboratories in a report released on Thursday, March 12th. Piper Sandler analyst I. Macpherson now forecasts that the oil and gas company will post earnings of $0.38 per share for the quarter, down from their […]
  • 03/16/2020

Core Lab Cuts Future Dividends To $0.01/Share; Announces Cost Control Plans

  • 03/16/2020

Citigroup Lowers Core Laboratories (NYSE:CLB) Price Target to $11.00

  • Core Laboratories (NYSE:CLB) had its price target cut by equities research analysts at Citigroup from $40.00 to $11.00 in a research note issued on Friday, BenzingaRatingsTable reports. The brokerage currently has a “neutral” rating on the oil and gas company’s stock. Citigroup‘s target price points to a potential upside of 29.56% from the stock’s previous […]
  • 03/15/2020

88 Stocks Moving In Friday's Mid-Day Session

  • Gainers CorePoint Lodging Inc. (NYSE: CPLG) gained 55.6% to $5.29 after the company reported results for its fourth quarter. OPKO Health, Inc. (NASDAQ: OPK) climbed 44.4% to $2....
  • 03/13/2020

136 Biggest Movers From Yesterday

  • Gainers Ranger Energy Services, Inc. (NYSE: RNGR) shares rose 44.8% to close at $4.46 on Thursday. Ampco-Pittsburgh Corporation (NYSE: AP) shares surged 35.6% to close at $3.20...
  • 03/13/2020

Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $11

  • 03/13/2020

Why Energy Stocks Are Getting Crushed Again Today

  • It's another brutal day in the oil market.
  • 03/12/2020

Stocks That Hit 52-Week Lows On Thursday

  • 03/12/2020

Core Laboratories (NYSE:CLB) Reaches New 12-Month Low After Analyst Downgrade

  • Core Laboratories (NYSE:CLB)’s stock price hit a new 52-week low during mid-day trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $17.00. Stifel Nicolaus currently has a hold rating on the stock. Core Laboratories traded as low as $11.71 and last traded at $12.12, with a volume of […]
  • 03/12/2020

Equitrans tops list of energy firms with highest long-term debt percentages

  • Plunging oil prices and the economic impact of the coronavirus could prompt a potential wave of debt restructurings and bankruptcies, especially in the energy and services sectors, analysts say.Oasis
  • 03/12/2020

Why Oil Service Stocks Are Getting Hammered Today

  • It's another brutal day in the oil market.
  • 03/11/2020

Stocks That Hit 52-Week Lows On Wednesday

  • During Wednesday's morning session, 690 stocks hit new 52-week lows. Intriguing Points: Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...
  • 03/11/2020

Bank of America Lowers Core Laboratories (NYSE:CLB) to Underperform

  • Core Laboratories (NYSE:CLB) was downgraded by research analysts at Bank of America from a “buy” rating to an “underperform” rating in a note issued to investors on Monday, Marketbeat reports. A number of other research firms have also weighed in on CLB. Citigroup raised their target price on Core Laboratories from $44.00 to $46.00 and […]
  • 03/11/2020

Core Laboratories (NYSE:CLB) Stock Rating Lowered by ValuEngine

  • Core Laboratories (NYSE:CLB) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Monday, ValuEngine reports. A number of other equities research analysts also recently issued reports on CLB. Bank of America downgraded shares of Core Laboratories from a “buy” rating to an […]
  • 03/11/2020

Core Laboratories (NYSE:CLB) Shares Gap Down Following Analyst Downgrade

  • Shares of Core Laboratories (NYSE:CLB) gapped down before the market opened on Tuesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $17.00. The stock had previously closed at $10.27, but opened at $13.52. Stifel Nicolaus currently has a hold rating on the stock. Core Laboratories shares last traded at $12.58, […]
  • 03/11/2020

BofA Downgrades 14 Oil And Gas Stocks In Face Of Oil Price War

  • Plummeting oil prices and uncertainty around the oil market in the midst of a price war between two big producing nations led Bank of America to downgrade nearly every stock in the sector that it didn't already rate Underperform, dropping the outlook on 14 stocks across the industry, from offshore drillers to equipment companies. Bank of America analyst Chase Mulvehill said in a Tuesday note the Saudi-Russia price war will ripple through the industry, and that U.S. shale will be the biggest victim. Mulvehill said U.S. Horizontal rig activity can be expected to collapse by nearly 35%, and expects U.S. onshore spending to drop considerably. Over the next couple years, shale could look pretty bleak. "At some point, the global oil market will need US Shale to grow … Full story available on Benzinga.com
  • 03/10/2020

Stifel Nicolaus Maintains a Hold Rating on Core Laboratories (CLB)

  • Stifel Nicolaus analyst Stephen Gengaro maintained a Hold rating on Core Laboratories (CLB) today and set a price target of $17.00. The company's shares
  • 03/10/2020

Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $17

  • 03/10/2020

5 Stocks With Falling Prices and High Yields

  • General Motors makes the list Continue reading...
  • 03/09/2020

5 Stocks With Falling Prices and High Yields

  • 5 Stocks With Falling Prices and High Yields, Stocks: AGM,BANR,CLB,CLF,GM, release date:Mar 09, 2020
  • 03/09/2020

Offshore Oil Stocks Get Hammered by Oil Price Rout

  • With OPEC at an impasse at its most recent emergency meeting, the price of oil is in free fall and is taking offshore oil businesses with it.
  • 03/09/2020

Oil-linked stocks see mass of downgrades on potential 'Energy Armageddon' HAL;SLB;HP;HLX;CLB;FET;WHD;AMNA;APA;CHK;DVN;OVV;EOG;MRO;OXY;CDEV;CPE;ESTE;FANG;MTDR;PE;PXD;REI;ROSE;WPX;XEC;CLR;ERF;NOG;WLL;MGY;WTI;SM;PDCE;NBL;BCEI;AXAS;VET;AM;ENLC;ET;OKE;PAA;PAGP;TELL;TRGP;BRY;GPOR;QEP

  • Oil-linked stocks see mass of downgrades on potential 'Energy Armageddon' HAL SLB HP HLX CLB FET WHD AMNA APA CHK DVN OVV EOG MRO OXY CDEV CPE ESTE FANG MTDR PE PXD REI ROSE WPX XEC CLR ERF NOG WLL MGY WTI SM PDCE NBL BCEI AXAS VET AM ENLC ET OKE PAA PAGP TELL TRGP BRY GPOR QEP
  • 03/09/2020
Unlock
CLB Ratings Summary
CLB Quant Ranking